Yes, a Japan Designated Marketing Authorization Holder (DMAH) can assist with clinical trial applications in Japan. They provide regulatory guidance, ensure compliance with local laws, and facilitate communication with Japanese authorities. Their expertise helps streamline the application process, ensuring timely approvals and adherence to Japan’s stringent regulatory requirements.
